HOME >> MEDICINE >> NEWS
Reduced risk for developing type 2 diabetes recommended for inclusion in Xenical's European label

Roche announced today that the European Union's Committee for Proprietary Medicinal Products (CPMP) has given a positive recommendation to extend the European label for its weight loss medication Xenical to include:

  • four year data on weight loss;
  • long-term safety and tolerability profile; and
  • reduced risk for developing type 2 diabetes.

    The decision is based on the results of the landmark XENDOS (XENical in the prevention of Diabetes in Obese Subjects) study, which showed for the first time that a weight loss medication could significantly reduce the risk of developing type 2 diabetes.

    XENDOS is the largest and longest study of a weight loss medication, treating 3304 patients for four years with Xenical plus lifestyle changes, or lifestyle changes alone. It is also the first study to assess whether treatment with a weight loss medication, Xenical, can reduce the risk of developing type 2 diabetes. The study showed that losing weight with Xenical reduced the risk of developing diabetes by 37% compared with lifestyle changes alone and by 52% in patients with impaired glucose tolerance (IGT or pre-diabetes). Compared to lifestyle changes alone, Xenical treatment produced significantly greater long-term weight loss and improvements in cardiovascular risk factors (including blood pressure and lipids). The study also confirmed that Xenical has a long-term safety profile that is unmatched in the field of weight loss.

    "The CPMP's decision is an important step towards expanding the European label for Xenical, which we believe will provide physicians with an effective strategy for helping patients lose weight and thereby delaying or preventing type 2 diabetes," commented Dr. Paul Brown, Life Cycle Leader for Xenical.

    The CPMP's positive opinion will now be proposed for approval by the European Commission.

    Type 2 diabetes

    Health experts have warned of a global epidemic of diabetes caused by a
    '"/>



  • Contact: Liz Gofton
    liz.gofton@shirehealthinternational.com
    44-207-471-1518
    Shire Health International
    30-Jan-2004


    Page: 1 2

    Related medicine news :

    1. Reduced progression of atherosclerosis tied to statin drugs lowering fats, protein
    2. Reduced risk of institutionalisation in patients with dementia
    3. Reduced exposure tobacco products lessen carcinogen exposure, but medicinal nicotine better
    4. Reduced scarring helps nerves grow through spinal injuries
    5. Reduced breastfeeding in western countries makes major contribution to incidence of breast cancer
    6. WIC, Medicaid Have Reduced Infant Deaths
    7. Cervical Screening Has Reduced Incidence And Mortality From Cervical Cancer
    8. Reduced Heart Disease Risk In Middle Age Lowers Eventual Medicare Costs
    9. Study Leads To New Standard Of Care For Treating Unstable Angina: Heart-Attack Risk Reduced By 47% With Use Of Tirofiban
    10. Hospital acquired infections present major problem for infants in developing countries
    11. Helping answer needs by developing specialists in autism

    Post Your Comments:
    *Name:
    *Comment:
    *Email:


    (Date:10/13/2017)... ... 13, 2017 , ... Many families have long-term insurance that covers care for ... a waiver for care if the client has a cognitive impairment diagnosis. , ... care, is often waived, so the benefits from their insurance start immediately,” said Mechell ...
    (Date:10/13/2017)... ... , ... Talented host, actor Rob Lowe, is introducing a ... episode of "Success Files," which is an award-winning educational program broadcasted on PBS ... in-depth with passion and integrity. , Sciatica occurs when the sciatic nerve in ...
    (Date:10/12/2017)... ... 12, 2017 , ... CitiDent and San Francisco dentists, Dr. ... Oventus O2Vent technology. As many as 18 million Americans are estimated to suffer ... Oral appliances can offer significant relief to about 75 percent of people with ...
    (Date:10/12/2017)... , ... October 12, 2017 , ... ... a leader in post-acute health care, have expanded their existing home health joint ... Health. , AccentCare has been operating a joint venture home health company with ...
    (Date:10/12/2017)... ... October 12, 2017 , ... On Saturday, October 21, the Health & ... by Moonlight to raise money for the American Heart Association Heart Walk. Teams of ... will work together to keep their treadmills moving for 5 hours. Treadmills will start ...
    Breaking Medicine News(10 mins):
    (Date:10/11/2017)... -- Caris Life Sciences ® , a leading innovator in ... medicine, today announced that St. Jude Medical Center,s Crosson ... as its 17 th member. Through participation with ... Institute will help develop standards of care and best ... cancer treatment more precise and effective. ...
    (Date:10/10/2017)... , Oct. 10, 2017  NDS received FDA 510(k) clearance in ... medical-grade battery-powered display stand specifically designed for endoscopy environments. An innovative ... into a clinical solution to support the improvement of patient outcomes, ... Design ... Solution ...
    (Date:10/5/2017)... 2017  In response to the nationwide opioid ... Surgeons (AAOMS) released prescribing recommendations that urge ibuprofen ... as a first-line therapy to manage a patient,s ... Recognizing the value and importance of ... Prescribing: Acute and Postoperative Pain Management" stresses that ...
    Breaking Medicine Technology:
    Cached News: